广东嘉应制药回购股份达总股本2.048% ，推进员工持股或股权激励计划

Group 1 - The company Guangdong Jiaying Pharmaceutical announced the progress of its share repurchase plan, with a total of 2.048% of its total share capital repurchased as of August 31, 2025 [1][3] - The repurchase plan was approved on December 12, 2024, aiming to buy back between 7 million and 13.5 million shares at a maximum price of 9.80 yuan per share, with a total repurchase amount not exceeding 132.3 million yuan [2] - As of August 31, 2025, the company had repurchased 10.396 million shares at a maximum price of 7.04 yuan per share [3] Group 2 - The company has complied with relevant regulations during the repurchase process, ensuring no repurchase occurred during significant events that could impact stock prices [4] - The company will make repurchase decisions based on market conditions and fulfill its information disclosure obligations in a timely manner [4]